2018
-
Regulator confirms Sun Pharma whistleblower complaint
The Securities Exchange Board of India (Sebi) has confirmed reports that it had received a whistleblower complaint against Sun Pharma.
12/13/2018 -
J&J throws shade at rival Novartis with psoriasis study
Johnson & Johnson says that its psoriasis medication, Tremfya, is more effective than another treatment developed by Novartis AG.
12/12/2018 -
FDA rejects reformulated opioid
Mallinckrodt announced this week that the FDA will not approve an abuse-deterrent version of the company’s opioid product, Roxicodone.
12/12/2018 -
Pfizer plant in Kansas repeatedly hit with form 483 infractions
Since 2012, Pfizer's Hospira plant in Kansas has received eight citations including infractions for cardboard in samples and failures to conduct investigations into discrepancies in batches of finished products
12/11/2018 -
Boehringer cuts nearly 300 jobs in France
The company's French workforce will see 327 jobs cut but will also see 32 new ones created.
12/11/2018 -
Dozens of generics companies investigated for running alleged ‘cartel’
An antitrust investigation that initially focused on two drugs has now widened to include 300 drugs and at least 16 companies.
12/10/2018 -
Lonza makes plans for major biomanufacturing plant in China
Swiss CDMO giant Lonza announced Monday that it’s partnering with GE Healthcare to build a new biomanufacturing facility in China.
12/10/2018 -
AstraZeneca partners on cancer tech center
AstraZeneca announced a new collaboration with Cancer Research UK to launch a center of excellence in genetic screening, cancer modeling and big data processing
12/10/2018 -
Gilead grabs Roche vet as CEO
Gilead Sciences has named Roche Holding's Daniel O’Day as its new chief executive.
12/10/2018 -
Roche wins key lung cancer combo approval
Roche Holding’s Tecentriq immunotherapy, in combination with Avastin and chemotherapy, won U.S. FDA approval as a first-line treatment for a type of lung cancer.
12/07/2018 -
Anti-pharma couple found dead
An elderly Pennsylvania couple, know for their personal crusade against McNeil Consumer Healthcare, was found dead outside their home.
12/07/2018 -
Tris Pharma recalls infant ibuprofen
Tris Pharma has voluntarily recalled three lots of Infants' Ibuprofen Concentrated Oral Suspension because the products have been found to potentially have higher concentrations of ibuprofen.
12/06/2018 -
Bayer stops trial of drug it hopes will be a blockbuster
Bayer has halted testing for vilaprisan, a new medication developed to treat uterine fibroids. The company said that it’s concerned about the risk of side effects uncovered in toxicology data.
12/05/2018 -
FDA gives Roche immunotherapy drug priority review
The FDA has awarded Roche an accelerated review of its immunotherapy drug, Tecentriq, to treat non small-cell lung cancer.
12/05/2018 -
FDA fast tracks Amgen myeloma treatment
The drugmaker's trial of its bispecific antibody for multiple myeloma found that seven out of ten patients given the second-highest dose of AMG420 responded to the drug
12/04/2018 -
Mylan recalls all batches of blood pressure drug in U.S.
The company recalled some batches two weeks ago but is now recalling 104 additional lots.
12/04/2018 -
Unilever nabs GSK nutrition business
After beating out potential bids from Nestle and Coca-Cola, Unilever has signed a deal to buy GlaxoSmithKline’s nutrition business, Horlicks, for $3.8 billion.
12/03/2018 -
Janssen affiliate and Dutch company ink $1.6B deal to develop cancer drug
Cilag, an affiliate of Janssen, is teaming up with a Netherlands-based biopharmac company called Argenx to develop a treatment for certain cancers.
12/03/2018 -
GSK bets big with Tesaro buy
GlaxoSmithKline has agreed to buy cancer biotech, Tesaro, for $5.1B.
12/03/2018 -
Annual Report: Cell, gene products with marketing authorization
ISCT publishes an annual report on global cell, gene therapy market authorization
11/30/2018